$217 Million is the total value of TRV GP IV, LLC's 4 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PLRX | New | PLIANT THERAPEUTICS, INC. | $69,233,000 | – | 2,132,867 | +100.0% | 31.90% | – |
| MGTA | MAGENTA THERAPEUTICS, INC. | $60,142,000 | +19.6% | 8,008,204 | 0.0% | 27.71% | -39.7% | |
| RVMD | REVOLUTION MEDICINES, INC. | $44,826,000 | +44.1% | 1,419,900 | 0.0% | 20.65% | -27.4% | |
| FULC | FULCRUM THERAPEUTICS, INC. | $42,856,000 | +53.2% | 2,343,154 | 0.0% | 19.74% | -22.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGENTA THERAPEUTICS, INC. | 17 | Q4 2022 | 100.0% |
| FULCRUM THERAPEUTICS, INC. | 17 | Q3 2023 | 25.6% |
| PLIANT THERAPEUTICS, INC. | 14 | Q3 2023 | 40.6% |
| REVOLUTION MEDICINES, INC. | 12 | Q4 2022 | 28.4% |
| TANGO THERAPEUTICS, INC. | 9 | Q3 2023 | 82.1% |
| RELAY THERAPEUTICS, INC. | 2 | Q4 2020 | 41.2% |
View TRV GP IV, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-02-21 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 4 | 2023-02-09 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-10 |
View TRV GP IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.